{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:16:17Z","timestamp":1761513377575},"reference-count":60,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>The role of testosterone in erectile dysfunction (ED) is increasingly recognized. It is suggested that assessment of testosterone deficiency in men with ED and symptoms of hypogonadism, prior to first-line treatment, may be a useful tool for improving therapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Aim<\/jats:title>\n                  <jats:p>In this prospective, observational, and longitudinal study, we investigated the effects of vardenafil treatment as adjunctive therapy to testosterone undecanoate in hypogonadal ED patients who failed to respond to testosterone treatment alone.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>One hundred twenty-nine testosterone deficient (serum total testosterone \u22643.4 ng\/mL) patients aged 56 \u00b1 3.9 years received intramuscular injections of long-acting parenteral testosterone undecanoate at 3-month intervals for 8 months mean follow-up.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Main Outcome Measures<\/jats:title>\n                  <jats:p>Scores on the International Index of Erectile Function Questionnaire-five items (IIEF-5) and partner survey scores were compared at baseline and posttreatment with testosterone therapy alone or in combination with vardenafil. Patient baseline demographics and concomitant disease were correlated with patients' IIEF-5 scores.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Seventy one (58.2%) responded well to monotherapy within 3 months. Nonresponders had lower testosterone levels and higher rates of concomitant diseases and smoking. Thirty-four of the 51 nonresponders accepted the addition of 20 mg vardenafil on demand. Efficacy assessments were measured by the IIEF\u2013erectile function domain (IIEF-EF, questions 1\u20135 plus 15, 30 points) and partner self-designed survey at baseline after 4\u20136 weeks and at study end point. Thirty out of 34 patients responded well to this combination. IIEF-EF Sexual Health Inventory for Men score improved from 12 to 24 (P &amp;lt; 0.0001), and partner survey showed significantly higher satisfaction (P &amp;lt; 0.001). These patients reported spontaneous or nocturnal and morning erections or tumescence. No changes in adverse effects were recorded.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These data suggest that combination therapy of testosterone and vardenafil is safe and effective in treating hypogonadal ED patients who failed to respond to testosterone monotherapy.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1111\/jsm.12378","type":"journal-article","created":{"date-parts":[[2013,11,20]],"date-time":"2013-11-20T11:54:43Z","timestamp":1384948483000},"page":"543-552","source":"Crossref","is-referenced-by-count":11,"title":["Combined Testosterone and Vardenafil Treatment for Restoring Erectile Function in Hypogonadal Patients who Failed to Respond to Testosterone Therapy Alone"],"prefix":"10.1093","volume":"11","author":[{"given":"Dany-Jan","family":"Yassin","sequence":"first","affiliation":[{"name":"Department of Urology \u00a0 , Braunschweig , Germany"},{"name":"Klinikum Braunschweig \u00a0 , Braunschweig , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aksam A.","family":"Yassin","sequence":"additional","affiliation":[{"name":"Institute of Urology\/Andrology \u00a0 , Norderstedt-Hamburg , Germany"},{"name":"Segeberger Kliniken \u00a0 , Norderstedt-Hamburg , Germany"},{"name":"Dresden International University , Dresden , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter G.","family":"Hammerer","sequence":"additional","affiliation":[{"name":"Department of Urology \u00a0 , Braunschweig , Germany"},{"name":"Klinikum Braunschweig \u00a0 , Braunschweig , Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2014,2,1]]},"reference":[{"key":"2024032602353180900_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0022-5347(17)34871-1","article-title":"Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study","volume":"151","author":"Feldman","year":"1994","journal-title":"J Urol"},{"key":"2024032602353180900_bib2","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1210\/er.2004-0013","article-title":"The decline of androgen levels in elderly men and its clinical and therapeutic implications","volume":"26","author":"Kaufman","year":"2005","journal-title":"Endocr Rev"},{"key":"2024032602353180900_bib3","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1743-6109.2006.00245.x","article-title":"Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence","volume":"3","author":"Traish","year":"2006","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.eururo.2007.02.034","article-title":"Testosterone and erectile function: From basic research to a new clinical paradigm for managing men with androgen insufficiency and erectile dysfunction","volume":"52","author":"Traish","year":"2007","journal-title":"Eur Urol"},{"key":"2024032602353180900_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1046\/j.1365-2265.2000.01118.x","article-title":"Androgens and penile erection: Evidence for a direct relationship between free testosterone and cavernous vasodilation in men with erectile dysfunction","volume":"53","author":"Aversa","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602353180900_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1440-1681.2003.03790.x","article-title":"Gender differences in the regulation of vascular tone","volume":"30","author":"Thompson","year":"2003","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2024032602353180900_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01275152","article-title":"The effects of testosterone on the cavernous tissue and erectile function","volume":"15","author":"Shabsigh","year":"1997","journal-title":"World J Urol"},{"key":"2024032602353180900_bib8","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1046\/j.1464-410x.2000.00598.x","article-title":"Delayed testosterone replacement restores nitric oxide synthase-containing nerve fibres and the erectile response in rat penis","volume":"85","author":"Baba","year":"2000","journal-title":"BJU Int"},{"key":"2024032602353180900_bib9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1210\/jcem-57-3-557","article-title":"The nature of androgen action on male sexuality: A combined laboratory-self-report study on hypogonadal men","volume":"57","author":"Kwan","year":"1983","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602353180900_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2265.2005.02350.x","article-title":"Effects of testosterone on sexual function in men: Results of a meta-analysis","volume":"63","author":"Isidori","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602353180900_bib11","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s00345-006-0131-x","article-title":"Significance of hypogonadism in erectile dysfunction","volume":"24","author":"Buvat","year":"2006","journal-title":"World J Urol"},{"key":"2024032602353180900_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjmed.2005.07.042","article-title":"Does testosterone have a role in erectile function?","volume":"119","author":"Mikhail","year":"2006","journal-title":"Am J Med"},{"key":"2024032602353180900_bib13","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1464-410X.2007.06756.x","article-title":"Effects of testosterone on erectile function: Implications for the therapy of erectile dysfunction","volume":"99","author":"Saad","year":"2007","journal-title":"BJU Int"},{"key":"2024032602353180900_bib14","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-5347(01)65062-6","article-title":"Testosterone supplementation for hypogonadal impotence: Assessment of biochemical measures and therapeutic outcomes","volume":"157","author":"Morales","year":"1997","journal-title":"J Urol"},{"key":"2024032602353180900_bib15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1677\/joe.1.06233","article-title":"The endocrinology of sexual arousal","volume":"186","author":"Bancroft","year":"2005","journal-title":"J Endocrinol"},{"key":"2024032602353180900_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1743-6109.2007.00442.x","article-title":"Improvement of sexual function in men with late-onset hypogonadism treated with testosterone only","volume":"4","author":"Yassin","year":"2007","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1530\/EJE-08-0830","article-title":"Comparison of long-acting testosterone undecanoate formulation versus testosterone enanthate on sexual function and mood in hypogonadal men","volume":"160","author":"Jockenh\u00f6vel","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"2024032602353180900_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1743-6109.2006.00267.x","article-title":"Testosterone undecanoate restores erectile function in a subset of patients with venous leakage: A series of case reports","volume":"3","author":"Yassin","year":"2006","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib19","doi-asserted-by":"crossref","first-page":"630","DOI":"10.2164\/jandrol.108.005264","article-title":"Testosterone improves erectile function in hypogonadal patients with venous leakage","volume":"29","author":"Kurbatov","year":"2008","journal-title":"J Androl"},{"key":"2024032602353180900_bib20","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S0022-5347(01)67675-4","article-title":"Visually stimulated erection in castrated men","volume":"153","author":"Greenstein","year":"1995","journal-title":"J Urol"},{"key":"2024032602353180900_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0094-0143(05)70138-5","article-title":"Hormonal erectile dysfunction. Evaluation and management","volume":"28","author":"Morales","year":"2001","journal-title":"Urol Clin North Am"},{"key":"2024032602353180900_bib22","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1210\/jcem.83.10.5060-1","article-title":"Issues in testosterone replacement in older men","volume":"83","author":"Bhasin","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2024032602353180900_bib23","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.clinthera.2011.09.029","article-title":"Focus on phosphodiesterase inhibitors for the treatment of erectile dysfunction in older men","volume":"33","author":"Lee","year":"2011","journal-title":"Clin Ther"},{"key":"2024032602353180900_bib24","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.eururo.2006.02.052","article-title":"Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: Results of a multicenter, randomized, double-blind, placebo-controlled trial","volume":"50","author":"Porst","year":"2006","journal-title":"Eur Urol"},{"key":"2024032602353180900_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1185\/030079903125001839","article-title":"Sildenafil in erectile dysfunction: A critical review","volume":"19","author":"Salonia","year":"2003","journal-title":"Curr Med Res Opin"},{"key":"2024032602353180900_bib26","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/j.1939-4640.2003.tb02686.x","article-title":"Effects of medical or surgical castration on erectile function in an animal model","volume":"24","author":"Traish","year":"2003","journal-title":"J Androl"},{"key":"2024032602353180900_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/j.1939-4640.2001.tb02582.x","article-title":"Efficacy and safety of sildenafil citrate for treatment of erectile dysfunction in a population with associated organic risk factors","volume":"22","author":"Guay","year":"2001","journal-title":"J Androl"},{"key":"2024032602353180900_bib28","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/endo.140.4.6655","article-title":"Effects of castration and androgen replacement on erectile function in a rabbit model","volume":"140","author":"Traish","year":"1999","journal-title":"Endocrinology"},{"key":"2024032602353180900_bib29","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/01.ju.0000132389.97804.d7","article-title":"Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone","volume":"172","author":"Shabsigh","year":"2004","journal-title":"J Urol"},{"key":"2024032602353180900_bib30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1743-6109.2004.10111.x","article-title":"Endocrine aspects of sexual dysfunction in men","volume":"1","author":"Morales","year":"2004","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1439-0272.2006.00712.x","article-title":"Testosterone and erectile function in hypogonadal men unresponsive to tadalafil: Results from an open-label uncontrolled study","volume":"38","author":"Yassin","year":"2006","journal-title":"Andrologia"},{"key":"2024032602353180900_bib32","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1046\/j.1365-2265.2003.01764.x","article-title":"Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction","volume":"58","author":"Aversa","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2024032602353180900_bib33","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/tam.6.2.94.99","article-title":"Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone","volume":"6","author":"Kalinchenko","year":"2003","journal-title":"Aging Male"},{"key":"2024032602353180900_bib34","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1743-6109.2005.00071.x","article-title":"Testosterone therapy can enhance erectile function response to sildenafil in patients with PADAM: A pilot study","volume":"2","author":"Shamloul","year":"2005","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib35","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.ijir.3901446","article-title":"Combined use of androgen and sildenafil for hypogonadal patients unresponsive to sildenafil alone","volume":"18","author":"Hwang","year":"2006","journal-title":"Int J Impot Res"},{"key":"2024032602353180900_bib36","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1439-0272.2009.00991.x","article-title":"Testosterone undecanoate improves erectile dysfunction in hypogonadal men with the metabolic syndrome refractory to treatment with phosphodiesterase type 5 inhibitors alone","volume":"43","author":"Garcia","year":"2011","journal-title":"Andrologia"},{"key":"2024032602353180900_bib37","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1743-6109.2010.01956.x","article-title":"Hypogonadal men nonresponders to the PDE5 inhibitor tadalafil benefit from normalization of testosterone levels with a 1% hydroalcoholic testosterone gel in the treatment of erectile dysfunction (TADTEST study)","volume":"8","author":"Buvat","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib38","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/01.ju.0000149870.36577.05","article-title":"Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?","volume":"173","author":"Greenstein","year":"2005","journal-title":"J Urol"},{"key":"2024032602353180900_bib39","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7326\/0003-4819-157-10-201211200-00004","article-title":"Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: A parallel, randomized trial","volume":"157","author":"Spitzer","year":"2012","journal-title":"Ann Intern Med"},{"key":"2024032602353180900_bib40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"key":"2024032602353180900_bib41","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/1756287209344992","article-title":"Testosterone and phosphodiesterase type-5 inhibitors: New strategy for preventing endothelial damage in internal and sexual medicine?","volume":"1","author":"Aversa","year":"2009","journal-title":"Ther Adv Urol"},{"key":"2024032602353180900_bib42","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/endo.136.4.7534702","article-title":"Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat","volume":"136","author":"Lugg","year":"1995","journal-title":"Endocrinology"},{"key":"2024032602353180900_bib43","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1095\/biolreprod55.3.567","article-title":"Androgen and pituitary control of penile nitric oxide synthase and erectile function in the rat","volume":"55","author":"Penson","year":"1996","journal-title":"Biol Reprod"},{"key":"2024032602353180900_bib44","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1095\/biolreprod59.6.1413","article-title":"Androgenic maintenance of inflow and veno-occlusion during erection in the rat","volume":"59","author":"Mills","year":"1998","journal-title":"Biol Reprod"},{"key":"2024032602353180900_bib45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0039-128X(99)00040-9","article-title":"Androgenic maintenance of the erectile response in the rat","volume":"64","author":"Mills","year":"1999","journal-title":"Steroids"},{"key":"2024032602353180900_bib46","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0090-4295(98)00233-7","article-title":"Androgen induction of DNA synthesis in the rat penis","volume":"52","author":"Shabsigh","year":"1998","journal-title":"Urology"},{"key":"2024032602353180900_bib47","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.eururo.2006.01.028","article-title":"EAU Guidelines on erectile dysfunction: An update","volume":"49","author":"Wespes","year":"2006","journal-title":"Eur Urol"},{"key":"2024032602353180900_bib48","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.eururo.2010.02.020","article-title":"Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation","volume":"57","author":"Hatzimouratidis","year":"2010","journal-title":"Eur Urol"},{"key":"2024032602353180900_bib49","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1743-6109.2012.02783.x","article-title":"Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment","volume":"10","author":"Buvat","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1743-6109.2012.02778.x","article-title":"Standard operational procedures for low sexual desire in men","volume":"10","author":"Rubio-Aurioles","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1439-0272.2008.00851.x","article-title":"Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone","volume":"40","author":"Yassin","year":"2008","journal-title":"Andrologia"},{"key":"2024032602353180900_bib52","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.maturitas.2012.03.012","article-title":"Erectile dysfunction and coronary disease: Evaluating the link","volume":"72","author":"Jackson","year":"2012","journal-title":"Maturitas"},{"key":"2024032602353180900_bib53","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/eje.1.02166","article-title":"Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes","volume":"154","author":"Kapoor","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"2024032602353180900_bib54","doi-asserted-by":"crossref","first-page":"828","DOI":"10.2337\/dc10-1233","article-title":"TIMES2 Investigators. Testosterone replacement in hypogonadal men with type 2 diabetes and\/or metabolic syndrome (the TIMES2 study)","volume":"34","author":"Jones","year":"2011","journal-title":"Diabetes Care"},{"key":"2024032602353180900_bib55","article-title":"Long-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry study","volume-title":"Int J Clin Pract","author":"Traish","year":"2013"},{"key":"2024032602353180900_bib56","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1743-6109.2012.02944.x","article-title":"The 20-year public health impact and direct cost of testosterone deficiency in U.S. men","volume":"10","author":"Moskovic","year":"2013","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib57","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1464-410X.2003.04532.x","article-title":"Hypogonadism and erectile dysfunction: Pathophysiological observations and therapeutic outcomes","volume":"92","author":"Morales","year":"2003","journal-title":"BJU Int"},{"key":"2024032602353180900_bib58","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1111\/j.1743-6109.2011.02416.x","article-title":"Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats","volume":"8","author":"Morelli","year":"2011","journal-title":"J Sex Med"},{"key":"2024032602353180900_bib59","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jsbmb.2012.02.007","article-title":"Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome","volume":"132","author":"Morelli","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2024032602353180900_bib60","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.1111\/j.1743-6109.2012.02946.x","article-title":"Testosterone\/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors","volume":"9","author":"Vignozzi","year":"2012","journal-title":"J Sex Med"}],"container-title":["The Journal of Sexual Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515306767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1743609515306767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/2\/543\/48358777\/jsm_11_2_543.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jsm\/article-pdf\/11\/2\/543\/48358777\/jsm_11_2_543.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T02:59:48Z","timestamp":1711421988000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jsm\/article\/11\/2\/543\/6958080"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,1]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,1]]},"published-print":{"date-parts":[[2014,2,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jsm.12378","relation":{},"ISSN":["1743-6109","1743-6095"],"issn-type":[{"value":"1743-6109","type":"electronic"},{"value":"1743-6095","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,2]]},"published":{"date-parts":[[2014,2,1]]}}}